Literature DB >> 16212682

Visuomotor control in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.

Annemieke I Buizer1, Leo M J De Sonneville, Marry M van den Heuvel-Eibrink, Charles Njiokiktjien, Anjo J P Veerman.   

Abstract

Treatment for childhood acute lymphoblastic leukemia (ALL), which includes CNS prophylaxis, is associated with central and peripheral neurotoxicity. The purpose of the present study was to analyze the effects of chemotherapy on various levels of visuomotor control in survivors of childhood ALL treated without cranial irradiation, and to identify risk factors for possible deficits. Visuomotor function was compared between children after treatment for ALL (n = 34), children after treatment for Wilms tumor, which consists of non-CNS directed chemotherapy (n = 38), and healthy controls (n = 151). Three tasks were administered: a simple visual reaction time task and two tasks measuring visuomotor control with one requiring a higher level of cognitive control than the other. Visuomotor deficits were detected only in the ALL group, with poorer performance restricted to the condition requiring the highest level of control. Significant risk factors for poorer performance were female gender and a short time since end of treatment, and a trend was found for a young age at diagnosis. A high cumulative methotrexate dose was an adverse predictive factor in girls. The results indicate that chemotherapy-induced central neurotoxicity in childhood ALL treatment is associated with higher order visuomotor control deficits. Girls appear to be particularly vulnerable.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16212682     DOI: 10.1017/S1355617705050666

Source DB:  PubMed          Journal:  J Int Neuropsychol Soc        ISSN: 1355-6177            Impact factor:   2.892


  19 in total

1.  Neurocognitive outcomes in long-term survivors of childhood acute lymphoblastic leukemia treated on contemporary treatment protocols: A systematic review.

Authors:  Yin Ting Cheung; Kevin R Krull
Journal:  Neurosci Biobehav Rev       Date:  2015-04-07       Impact factor: 8.989

2.  Cognitive, behaviour, and academic functioning in adolescent and young adult survivors of childhood acute lymphoblastic leukaemia: a report from the Childhood Cancer Survivor Study.

Authors:  Lisa M Jacola; Kim Edelstein; Wei Liu; Ching-Hon Pui; Robert Hayashi; Nina S Kadan-Lottick; Deokumar Srivastava; Tara Henderson; Wendy Leisenring; Leslie L Robison; Gregory T Armstrong; Kevin R Krull
Journal:  Lancet Psychiatry       Date:  2016-09-14       Impact factor: 27.083

3.  Long-term psychological and educational outcomes for survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study.

Authors:  Daniel J Zheng; Kevin R Krull; Yan Chen; Lisa Diller; Yutaka Yasui; Wendy Leisenring; Pim Brouwers; Rebecca Howell; Jin-Shei Lai; Lyn Balsamo; Kevin C Oeffinger; Leslie L Robison; Gregory T Armstrong; Nina S Kadan-Lottick
Journal:  Cancer       Date:  2018-06-11       Impact factor: 6.860

4.  Associating Physical Activity Levels with Motor Performance and Physical Function in Childhood Survivors of Acute Lymphoblastic Leukemia.

Authors:  Stanley H Hung; Anne Rankin; Naznin Virji-Babul; Sheila Pritchard; Christopher Fryer; Kristin L Campbell
Journal:  Physiother Can       Date:  2017       Impact factor: 1.037

5.  The Association Between Motor Skills and Academic Achievement Among Pediatric Survivors of Acute Lymphoblastic Leukemia.

Authors:  Lyn M Balsamo; Kyaw J Sint; Joseph P Neglia; Pim Brouwers; Nina S Kadan-Lottick
Journal:  J Pediatr Psychol       Date:  2015-10-29

Review 6.  Neurodevelopmental consequences of pediatric cancer and its treatment: applying an early adversity framework to understanding cognitive, behavioral, and emotional outcomes.

Authors:  Hilary A Marusak; Allesandra S Iadipaolo; Felicity W Harper; Farrah Elrahal; Jeffrey W Taub; Elimelech Goldberg; Christine A Rabinak
Journal:  Neuropsychol Rev       Date:  2017-12-22       Impact factor: 7.444

7.  F2-isoprostanes: a measure of oxidative stress in children receiving treatment for leukemia.

Authors:  Marilyn J Hockenberry; Olga A Taylor; Patricia M Gundy; Adam K Ross; Alice Pasvogel; David Montgomery; Phillip Ribbeck; Kathy McCarthy; Ida Moore
Journal:  Biol Res Nurs       Date:  2013-08-15       Impact factor: 2.522

8.  Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.

Authors:  Lisa M Jacola; Kevin R Krull; Ching-Hon Pui; Deqing Pei; Cheng Cheng; Wilburn E Reddick; Heather M Conklin
Journal:  J Clin Oncol       Date:  2016-02-08       Impact factor: 44.544

9.  Cognitive outcomes following contemporary treatment without cranial irradiation for childhood acute lymphoblastic leukemia.

Authors:  H M Conklin; K R Krull; W E Reddick; D Pei; C Cheng; C H Pui
Journal:  J Natl Cancer Inst       Date:  2012-08-27       Impact factor: 13.506

Review 10.  Quantitative morphologic evaluation of magnetic resonance imaging during and after treatment of childhood leukemia.

Authors:  Wilburn E Reddick; Fred H Laningham; John O Glass; Ching-Hon Pui
Journal:  Neuroradiology       Date:  2007-07-26       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.